In a story July 7, 2020, about business-related fallout from the coronavirus pandemic, The Associated Press erroneously reported Regeneron Pharmaceuticals is working on a COVID-19 vaccine candidate. The drug, REGN-COV2, is a double antibody combination being studied for potential treatment and prevention of the disease, not a vaccine.
Correction: Virus Outbreak-Business Fallout story
Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.